Brokers Offer Predictions for AKRO Q1 Earnings
Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for Akero Therapeutics in a note issued to investors on Thursday, September 4th. HC Wainwright analyst A. Fein anticipates that the company will post earnings of

What's Your Reaction?











